Bleakley Financial Group, LLC Bio Rad Laboratories, Inc. Transaction History

Bleakley Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $47,984 - $57,900	137 Added 25.42%	676 $242 Million
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $123,305 - $166,835	-343 Reduced 38.89%	539 $204 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $6,280 - $7,545	-15 Reduced 1.67%	882 $422 Million
Q4 2022 Feb 07, 2023	BUY	$351.71 - $456.01 $315,483 - $409,040	897 New	897 $377 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.